Exit Notice
You are about to leave ClinicalTrials.gov and go to: A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer URL: https://trials.lilly.com/en-US/trial/97404
Click on the link to continue or return to ClinicalTrials.gov Home